SCHEMBL8307862

SCHEMBL8307862

CC(=NOCCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccc(S(=O)(=O)c2ccccn2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 15/20 0.64
RXRA P19793 2/20 0.47
RARG P13631 1/20 0.47
FFAR1 O14842 4/20 0.47
ESR1 P03372 1/20 0.45
HRH3 Q9Y5N1 1/20 0.44
CYP3A4 P08684 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MPC2 O95563 1/20 0.42
CYP2C8 P10632 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307858 1.00 PPARG (0.64) PPARGRXRARARGFFAR1ESR1
SCHEMBL6898710 0.90 PPARG (0.70) PPARGFFAR1HRH3CYP3A4MEN1
SCHEMBL6898705 0.90 PPARG (0.70) PPARGFFAR1HRH3CYP3A4MEN1
SCHEMBL8304565 0.89 PPARG (0.73) PPARGRXRARARGFFAR1HRH3
SCHEMBL8304563 0.89 PPARG (0.73) PPARGRXRARARGFFAR1HRH3
SCHEMBL8308978 0.88 PPARG (0.63) PPARGRXRAFFAR1HRH3CYP3A4
SCHEMBL8308972 0.88 PPARG (0.63) PPARGRXRAFFAR1HRH3CYP3A4
SCHEMBL1131019 0.85 PPARG (0.78) PPARGRXRARARGFFAR1ESR1
SCHEMBL6934348 0.85 PPARG (0.78) PPARGRXRARARGFFAR1ESR1
Hydrochloric Acid SCHEMBL8446836 0.84 PPARG (0.77) PPARGRXRARARGFFAR1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed